Adriana Tajonar
Director/Board Member at A2 Biotherapeutics, Inc.
Network origin in Adriana Tajonar first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Adriana Tajonar via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Private Equity Investor | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Director/Board Member | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Consultant / Advisor | |
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Biotechnology | Chairman Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree | |
| Tentarix Biotherapeutics, Inc. | Director/Board Member Director/Board Member | ||
Tentarix Biotherapeutics LP
 Tentarix Biotherapeutics LP BiotechnologyHealth Technology Tentarix Biotherapeutics LP operates as a biotechnology company. The company is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Private Equity Investor Private Equity Investor | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder | |
Chinook Therapeutics U.S., Inc.
 Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | Information Technology Services | Director/Board Member Director/Board Member | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Director/Board Member | |
| East Carolina University | College/University | Masters Business Admin | |
| Indian Institute of Technology Bombay | College/University | Undergraduate Degree | |
| Puerto Rico USA Citizenship Foundation | Corporate Officer/Principal | ||
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| State University of New York at Buffalo | College/University | Graduate Degree | |
| Versant Ventures VI GP-GP LLC | Corporate Officer/Principal | ||
| CATALENT, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DARÉ BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Director/Board Member | |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Biotechnology | Director/Board Member | |
| STEVANATO GROUP S.P.A. | Medical Specialties | Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
BlueRock Therapeutics LP
 BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal | |
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Chairman | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Chairman | |
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Director/Board Member | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member | |
Versant Venture Capital VI (Canada) LP
 Versant Venture Capital VI (Canada) LP Investment ManagersFinance Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA. | Investment Managers | Director/Board Member |
Statistics
International
| United States | 40 |
| Canada | 7 |
| India | 2 |
| Germany | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 6 |
| Technology Services | 2 |
Operational
| Director/Board Member | 155 |
| Corporate Officer/Principal | 47 |
| Independent Dir/Board Member | 40 |
| Chairman | 19 |
| Private Equity Investor | 18 |
Most connected contacts
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Helen Kim | 34 |
| Jerel Davis | 29 |
| David Goeddel | 27 |
| Susan Kelley | 22 |
| Carlo Rizzuto | 22 |
| Jakob Loven | 19 |
| David Chang | 16 |
| Madhavan Balachandran | 15 |
| Josh Richardson | 9 |
| Alexander Kamb | 3 |
| Darrin Miles | 3 |
| Michael L. Gallo | 2 |
| David Chang | 1 |
| Klaus Hoeflich | 1 |
- Stock Market
- Insiders
- Adriana Tajonar
- Company connections
